['ANTIARRHYTHMICS: AMIODARONE, QUINIDINE', 'CONTRAINDICATED DUE TO POTENTIAL FOR SERIOUS AND/OR LIFE THREATENING REACTIONS SUCH AS CARDIAC ARRHYTHMIAS.', 'ANTIMYCOBACTERIAL: RIFAMPIN', 'MAY LEAD TO LOSS OF VIROLOGIC RESPONSE AND POSSIBLE RESISTANCE TO VIRACEPT OR OTHER COADMINISTERED ANTIRETROVIRAL AGENTS.', 'ERGOT DERIVATIVES: DIHYDROERGOTAMINE, ERGONOVINE, ERGOTAMINE, METHYLERGONOVINE', 'CONTRAINDICATED DUE TO POTENTIAL FOR SERIOUS AND/OR LIFE THREATENING REACTIONS SUCH AS ACUTE ERGOT TOXICITY CHARACTERIZED BY PERIPHERAL VASOSPASM AND ISCHEMIA OF THE EXTREMITIES AND OTHER TISSUES.', "HERBAL PRODUCTS: ST. JOHN'S WORT (HYPERICUM PERFORATUM)", 'MAY LEAD TO LOSS OF VIROLOGIC RESPONSE AND POSSIBLE RESISTANCE TO VIRACEPT OR OTHER COADMINISTERED ANTIRETROVIRAL AGENTS.', 'HMG-COA REDUCTASE INHIBITORS: LOVASTATIN, SIMVASTATIN', 'POTENTIAL FOR SERIOUS REACTIONS SUCH AS RISK OF MYOPATHY INCLUDING RHABDOMYOLYSIS.', 'NEUROLEPTIC: PIMOZIDE', 'CONTRAINDICATED DUE TO POTENTIAL FOR SERIOUS AND/OR LIFE THREATENING REACTIONS SUCH AS CARDIAC ARRHYTHMIAS.', 'PROTON PUMP INHIBITORS', 'OMEPRAZOLE DECREASES THE PLASMA CONCENTRATIONS OF NELFINAVIR. CONCOMITANT USE OF PROTON PUMP INHIBITORS AND VIRACEPT MAY LEAD TO A LOSS OF VIROLOGIC RESPONSE AND DEVELOPMENT OF RESISTANCE.', 'SEDATIVE/HYPNOTICS: MIDAZOLAM, TRIAZOLAM', 'CONTRAINDICATED DUE TO POTENTIAL FOR SERIOUS AND/OR LIFE THREATENING REACTIONS SUCH AS PROLONGED OR INCREASED SEDATION OR RESPIRATORY DEPRESSION.']